ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP2877	Vitamin D receptor pathway	18/185	143/6033	2.82251269346921e-07	7.33853300301995e-05	7.3088223430887e-05	604/820/634/78989/1543/1591/168002/1946/727936/9173/27035/6279/6280/219855/25928/79689/8600/54210	18
WP2848	Pluripotent stem cell differentiation pathway	6/185	34/6033	0.000503840704249542	0.0654992915524404	0.0652341122344143	3577/22943/2246/10637/7018/8600	6
WP1423	Ganglio sphingolipid metabolism	3/185	10/6033	0.00290356244968798	0.251642078972959	0.250623285130963	8708/30815/6489	3
WP3527	Pre-implantation embryo	5/185	35/6033	0.00394778438799136	0.256605985219438	0.25556709459102	366/1958/2354/4603/7004	5
WP5188	Retinol metabolism	3/185	12/6033	0.00508747162755589	0.264548524632906	0.263477477974473	1543/10170/195814	3
WP24	Peptide GPCRs	5/185	41/6033	0.00786018804013643	0.314830301230822	0.313555684626649	3577/2358/4886/4887/5540	5
WP5083	Neuroinflammation and glutamatergic signaling	9/185	115/6033	0.00847620041775291	0.314830301230822	0.313555684626649	816/1610/2893/2904/2918/7850/6506/6513/92745	9
WP455	GPCRs, class A rhodopsin-like	9/185	118/6033	0.0099665276610787	0.323912148985058	0.322600763766495	1238/136/3577/2358/2852/3357/4886/4887/5540	9
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	6/185	65/6033	0.0141425384100022	0.408562220733397	0.406908122673748	22943/2354/8456/25928/11005/7704	6
WP5094	Orexin receptor pathway	8/185	112/6033	0.0211912863331674	0.550973444662352	0.548742782943072	655/1958/2354/2904/4314/6506/6513/114088	8
WP1533	Vitamin B12 metabolism	4/185	37/6033	0.0256810818263952	0.607007388623886	0.604549868831887	3043/6288/6289/6947	4
WP4917	Proximal tubule transport	4/185	42/6033	0.0387071235464837	0.838654343507147	0.835258981792543	760/762/6513/160728	4
WP3930	EDA signaling in hair follicle development	2/185	11/6033	0.0428826523344026	0.84409400380926	0.840676619178453	22943/25928	2
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5/185	65/6033	0.0482864980764586	0.84409400380926	0.840676619178453	816/22943/84623/4868/5329	5
WP4698	Vitamin D-sensitive calcium signaling in depression	3/185	29/6033	0.0578267266546501	0.84409400380926	0.840676619178453	793/2904/3786	3
WP3958	GPR40 pathway	2/185	13/6033	0.0584372771867949	0.84409400380926	0.840676619178453	5333/113026	2
WP4723	Omega-3 / omega-6 fatty acid synthesis	2/185	13/6033	0.0584372771867949	0.84409400380926	0.840676619178453	9415/5322	2
WP4724	Omega-9 fatty acid synthesis	2/185	13/6033	0.0584372771867949	0.84409400380926	0.840676619178453	79071/9415	2
WP5115	Network map of SARS-CoV-2 signaling pathway	10/185	190/6033	0.0662356458953565	0.868866116035683	0.865348439452542	9332/3577/1958/3043/10410/7850/6288/6289/5104/7018	10
WP3971	OSX and miRNAs in tooth development	2/185	14/6033	0.0668358550796679	0.868866116035683	0.865348439452542	655/22943	2
WP3624	Lung fibrosis	4/185	52/6033	0.0742036282562882	0.892071544291889	0.888459918606497	655/2246/727897/729238	4
WP5053	Development of ureteric collection system	4/185	53/6033	0.0784294254719132	0.892071544291889	0.888459918606497	655/168667/9620/3237	4
WP247	Small ligand GPCRs	2/185	16/6033	0.0847157998254841	0.892071544291889	0.888459918606497	9294/1903	2
WP117	GPCRs, other	3/185	37/6033	0.103248123076235	0.892071544291889	0.888459918606497	9620/3577/2918	3
WP5149	Lipid metabolism in senescent cells	2/185	18/6033	0.103844389291905	0.892071544291889	0.888459918606497	8399/5322	2
WP43	Oxidation by cytochrome P450	3/185	38/6033	0.109694917765455	0.892071544291889	0.888459918606497	1543/1591/339761	3
WP383	Striated muscle contraction pathway	2/185	21/6033	0.134415788857739	0.892071544291889	0.888459918606497	7134/7273	2
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	4/185	68/6033	0.15484239956821	0.892071544291889	0.888459918606497	816/820/1591/5333	4
WP2865	IL1 and megakaryocytes in obesity	2/185	23/6033	0.155774602356712	0.892071544291889	0.888459918606497	6280/8991	2
WP3658	Wnt/beta-catenin signaling pathway in leukemia	2/185	23/6033	0.155774602356712	0.892071544291889	0.888459918606497	22943/7704	2
WP129	Matrix metalloproteinases	2/185	24/6033	0.166683923186161	0.892071544291889	0.888459918606497	4326/4314	2
WP26	S1P receptor signal transduction	2/185	24/6033	0.166683923186161	0.892071544291889	0.888459918606497	9294/1903	2
WP5205	Clock-controlled autophagy in bone metabolism	4/185	71/6033	0.172650760566648	0.892071544291889	0.888459918606497	79365/22943/5187/8600	4
WP4900	Purinergic signaling	2/185	25/6033	0.177720881340646	0.892071544291889	0.888459918606497	136/286530	2
WP176	Folate metabolism	3/185	48/6033	0.181486504350534	0.892071544291889	0.888459918606497	3043/6288/6289	3
WP558	Complement and coagulation cascades	3/185	48/6033	0.181486504350534	0.892071544291889	0.888459918606497	1191/5329/5104	3
WP241	One-carbon metabolism	2/185	26/6033	0.188867526308792	0.892071544291889	0.888459918606497	23382/10840	2
WP299	Nuclear receptors in lipid metabolism and toxicity	2/185	26/6033	0.188867526308792	0.892071544291889	0.888459918606497	8647/1591	2
WP4875	Disruption of postsynaptic signaling by CNV	2/185	26/6033	0.188867526308792	0.892071544291889	0.888459918606497	816/2904	2
WP2806	Complement system	4/185	75/6033	0.197427346780753	0.892071544291889	0.888459918606497	2214/5329/729238/11326	4
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	6/185	128/6033	0.198831998243678	0.892071544291889	0.888459918606497	1958/9734/3359/5452/7018/11076	6
WP2882	Nuclear receptors meta-pathway	11/185	268/6033	0.199037051824193	0.892071544291889	0.888459918606497	8647/1543/1958/9982/55554/81706/9588/6286/6513/160728/11254	11
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	2/185	27/6033	0.200106877516759	0.892071544291889	0.888459918606497	4314/27035	2
WP4481	Resistin as a regulator of inflammation	2/185	28/6033	0.211422882257326	0.892071544291889	0.888459918606497	5333/113026	2
WP408	Oxidative stress response	2/185	29/6033	0.222800375264931	0.892071544291889	0.888459918606497	1543/27035	2
WP2406	Cardiac progenitor differentiation	2/185	31/6033	0.245683370717155	0.892071544291889	0.888459918606497	22943/55897	2
WP3584	MECP2 and associated Rett syndrome	3/185	56/6033	0.245735040159932	0.892071544291889	0.888459918606497	604/2893/54715	3
WP4018	Clear cell renal cell carcinoma pathways	4/185	83/6033	0.249822414832236	0.892071544291889	0.888459918606497	79365/3099/197257/6513	4
WP3298	Melatonin metabolism and effects	2/185	32/6033	0.257162637861877	0.892071544291889	0.888459918606497	1543/5187	2
WP4823	Genes controlling nephrogenesis	2/185	32/6033	0.257162637861877	0.892071544291889	0.888459918606497	3237/4868	2
WP2007	Iron metabolism in placenta	1/185	10/6033	0.267786385750045	0.892071544291889	0.888459918606497	7018	1
WP4259	Disorders of folate metabolism and transport	1/185	10/6033	0.267786385750045	0.892071544291889	0.888459918606497	10840	1
WP4389	Bile acids synthesis and enterohepatic circulation 	1/185	10/6033	0.267786385750045	0.892071544291889	0.888459918606497	8647	1
WP15	Selenium micronutrient network	3/185	59/6033	0.270722722448244	0.892071544291889	0.888459918606497	3043/6288/6289	3
WP4008	NO/cGMP/PKG mediated neuroprotection	2/185	34/6033	0.280136733407381	0.892071544291889	0.888459918606497	816/2904	2
WP2884	NRF2 pathway	5/185	116/6033	0.283142897497327	0.892071544291889	0.888459918606497	1958/9588/6513/160728/11254	5
WP4271	Vitamin B12 disorders	1/185	11/6033	0.290276759091609	0.892071544291889	0.888459918606497	6947	1
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	1/185	11/6033	0.290276759091609	0.892071544291889	0.888459918606497	604	1
WP4629	Aerobic glycolysis	1/185	11/6033	0.290276759091609	0.892071544291889	0.888459918606497	6513	1
WP4788	Autosomal recessive osteopetrosis pathways	1/185	11/6033	0.290276759091609	0.892071544291889	0.888459918606497	8600	1
WP5052	Nephrogenesis	1/185	11/6033	0.290276759091609	0.892071544291889	0.888459918606497	655	1
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	1/185	11/6033	0.290276759091609	0.892071544291889	0.888459918606497	2358	1
WP5130	Th17 cell differentiation pathway	3/185	62/6033	0.295978655391204	0.892071544291889	0.888459918606497	50615/9572/5187	3
WP2447	Amyotrophic lateral sclerosis (ALS)	2/185	36/6033	0.303059721581581	0.892071544291889	0.888459918606497	4741/6506	2
WP4754	IL-18 signaling pathway	9/185	239/6033	0.311256251509327	0.892071544291889	0.888459918606497	2904/8870/81618/10365/4314/27035/7018/7052/8600	9
WP2023	Cell differentiation - expanded index	1/185	12/6033	0.312079947329413	0.892071544291889	0.888459918606497	10637	1
WP2881	Estrogen receptor pathway	1/185	12/6033	0.312079947329413	0.892071544291889	0.888459918606497	1543	1
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	1/185	12/6033	0.312079947329413	0.892071544291889	0.888459918606497	22943	1
WP4211	Transcriptional cascade regulating adipogenesis	1/185	12/6033	0.312079947329413	0.892071544291889	0.888459918606497	10365	1
WP5110	Familial hyperlipidemia type 3	1/185	12/6033	0.312079947329413	0.892071544291889	0.888459918606497	7436	1
WP5173	Disorders of galactose metabolism 	1/185	12/6033	0.312079947329413	0.892071544291889	0.888459918606497	5836	1
WP4148	Splicing factor NOVA regulated synaptic proteins	2/185	37/6033	0.314477527210459	0.892071544291889	0.888459918606497	1946/2904	2
WP2857	Mesodermal commitment pathway	5/185	122/6033	0.319331904299516	0.892071544291889	0.888459918606497	655/1466/22943/8325/10637	5
WP2880	Glucocorticoid receptor pathway	3/185	65/6033	0.321374848290573	0.892071544291889	0.888459918606497	9982/81706/6286	3
WP5218	Extrafollicular B cell activation by SARS-CoV-2	3/185	65/6033	0.321374848290573	0.892071544291889	0.888459918606497	57379/60468/604	3
WP185	Integrin-mediated cell adhesion	4/185	94/6033	0.325758623555337	0.892071544291889	0.888459918606497	11131/827/3681/84665	4
WP500	Glycogen synthesis and degradation	2/185	38/6033	0.325854338846292	0.892071544291889	0.888459918606497	3099/5836	2
WP2289	Drug induction of bile acid pathway	1/185	13/6033	0.333216836507964	0.892071544291889	0.888459918606497	8647	1
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1/185	13/6033	0.333216836507964	0.892071544291889	0.888459918606497	7134	1
WP5176	Disorders of bile acid synthesis and biliary transport	1/185	13/6033	0.333216836507964	0.892071544291889	0.888459918606497	8647	1
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	1/185	13/6033	0.333216836507964	0.892071544291889	0.888459918606497	1903	1
WP3937	Microglia pathogen phagocytosis pathway	2/185	39/6033	0.337181963716763	0.892071544291889	0.888459918606497	54210/54209	2
WP5097	CCL18 signaling pathway	2/185	39/6033	0.337181963716763	0.892071544291889	0.888459918606497	6513/7004	2
WP534	Glycolysis and gluconeogenesis	2/185	39/6033	0.337181963716763	0.892071544291889	0.888459918606497	3099/6513	2
WP536	Calcium regulation in cardiac cells	5/185	125/6033	0.337647735014904	0.892071544291889	0.888459918606497	782/816/2707/5569/8787	5
WP4222	Phosphodiesterases in neuronal function	2/185	40/6033	0.348452744571171	0.892071544291889	0.888459918606497	2904/5145	2
WP4312	Rett syndrome causing genes	2/185	40/6033	0.348452744571171	0.892071544291889	0.888459918606497	2904/6334	2
WP12	Osteoclast signaling	1/185	14/6033	0.353707681233218	0.892071544291889	0.888459918606497	8600	1
WP2879	Farnesoid X receptor pathway	1/185	14/6033	0.353707681233218	0.892071544291889	0.888459918606497	8647	1
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/185	14/6033	0.353707681233218	0.892071544291889	0.888459918606497	1466	1
WP4584	Biomarkers for pyrimidine metabolism disorders	1/185	14/6033	0.353707681233218	0.892071544291889	0.888459918606497	1152	1
WP58	Monoamine GPCRs	1/185	14/6033	0.353707681233218	0.892071544291889	0.888459918606497	3357	1
WP697	Estrogen metabolism	1/185	14/6033	0.353707681233218	0.892071544291889	0.888459918606497	1543	1
WP5220	Metabolic reprogramming in pancreatic cancer	2/185	41/6033	0.359659534845998	0.892071544291889	0.888459918606497	3099/6513	2
WP3594	Circadian rhythm genes	6/185	159/6033	0.361500181333949	0.892071544291889	0.888459918606497	79365/1958/4887/9572/5187/60675	6
WP4673	Male infertility	4/185	100/6033	0.367935358367843	0.892071544291889	0.888459918606497	1191/1543/8787/128153	4
WP1946	Cori cycle	1/185	15/6033	0.373572123660839	0.892071544291889	0.888459918606497	6513	1
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	1/185	15/6033	0.373572123660839	0.892071544291889	0.888459918606497	255738	1
WP5109	Familial hyperlipidemia type 2	1/185	15/6033	0.373572123660839	0.892071544291889	0.888459918606497	255738	1
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	2/185	43/6033	0.381854968837696	0.892071544291889	0.888459918606497	816/2904	2
WP5095	Overview of proinflammatory and profibrotic mediators	3/185	73/6033	0.388918516445564	0.892071544291889	0.888459918606497	6369/29949/4314	3
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	1/185	16/6033	0.39282921191653	0.892071544291889	0.888459918606497	8325	1
WP4478	LTF danger signal response pathway	1/185	16/6033	0.39282921191653	0.892071544291889	0.888459918606497	54210	1
WP410	Exercise-induced circadian regulation	2/185	44/6033	0.392831663214632	0.892071544291889	0.888459918606497	5187/10381	2
WP4971	Phosphoinositides metabolism	2/185	44/6033	0.392831663214632	0.892071544291889	0.888459918606497	5333/113026	2
WP4538	Regulatory circuits of the STAT3 signaling pathway	3/185	75/6033	0.405602739525324	0.892071544291889	0.888459918606497	1844/53832/50615	3
WP3287	Overview of nanoparticle effects	1/185	17/6033	0.411497417965299	0.892071544291889	0.888459918606497	3681	1
WP3967	miR-509-3p alteration of YAP1/ECM axis	1/185	17/6033	0.411497417965299	0.892071544291889	0.888459918606497	7004	1
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	1/185	17/6033	0.411497417965299	0.892071544291889	0.888459918606497	1591	1
WP5074	Kallmann syndrome	1/185	17/6033	0.411497417965299	0.892071544291889	0.888459918606497	60675	1
WP691	Tamoxifen metabolism	1/185	17/6033	0.411497417965299	0.892071544291889	0.888459918606497	1543	1
WP2849	Hematopoietic stem cell differentiation	2/185	46/6033	0.414516323588829	0.892071544291889	0.888459918606497	2354/23650	2
WP4533	Transcription co-factors SKI and SKIL protein partners	1/185	18/6033	0.429594654946087	0.892071544291889	0.888459918606497	7004	1
WP4760	PKC-gamma calcium signaling pathway in ataxia	1/185	18/6033	0.429594654946087	0.892071544291889	0.888459918606497	2893	1
WP497	Urea cycle and metabolism of amino groups	1/185	18/6033	0.429594654946087	0.892071544291889	0.888459918606497	1152	1
WP734	Serotonin receptor 4/6/7 and NR3C signaling	1/185	18/6033	0.429594654946087	0.892071544291889	0.888459918606497	1958	1
WP3646	Hepatitis C and hepatocellular carcinoma	2/185	48/6033	0.435811690425254	0.892071544291889	0.888459918606497	3577/7345	2
WP2895	Differentiation of white and brown adipocyte	1/185	19/6033	0.447138293987645	0.892071544291889	0.888459918606497	655	1
WP325	Triacylglyceride synthesis	1/185	19/6033	0.447138293987645	0.892071544291889	0.888459918606497	56895	1
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	1/185	19/6033	0.447138293987645	0.892071544291889	0.888459918606497	8708	1
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	1/185	19/6033	0.447138293987645	0.892071544291889	0.888459918606497	6513	1
WP4722	Glycerolipids and glycerophospholipids	1/185	19/6033	0.447138293987645	0.892071544291889	0.888459918606497	56895	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/185	19/6033	0.447138293987645	0.892071544291889	0.888459918606497	3357	1
WP560	TGF-beta receptor signaling	2/185	50/6033	0.456685612225555	0.892071544291889	0.888459918606497	25805/10637	2
WP167	Eicosanoid synthesis	1/185	20/6033	0.464145180521115	0.892071544291889	0.888459918606497	5322	1
WP2878	PPAR-alpha pathway	1/185	20/6033	0.464145180521115	0.892071544291889	0.888459918606497	55554	1
WP5044	Kynurenine pathway and links to cell senescence	1/185	20/6033	0.464145180521115	0.892071544291889	0.888459918606497	7850	1
WP673	ErbB signaling pathway	3/185	83/6033	0.470795628887109	0.892071544291889	0.888459918606497	816/2069/145957	3
WP1772	Apoptosis modulation and signaling	3/185	84/6033	0.478729481975615	0.892071544291889	0.888459918606497	638/8739/7850	3
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	1/185	21/6033	0.480631650104283	0.892071544291889	0.888459918606497	1591	1
WP3591	Sleep regulation	1/185	22/6033	0.496613543772066	0.892071544291889	0.888459918606497	4887	1
WP4537	Hippo-Yap signaling pathway	1/185	22/6033	0.496613543772066	0.892071544291889	0.888459918606497	7004	1
WP712	Estrogen signaling pathway	1/185	22/6033	0.496613543772066	0.892071544291889	0.888459918606497	2852	1
WP3942	PPAR signaling pathway	2/185	54/6033	0.497066286468314	0.892071544291889	0.888459918606497	9415/28965	2
WP4816	TGF-beta receptor signaling in skeletal dysplasias	2/185	54/6033	0.497066286468314	0.892071544291889	0.888459918606497	25805/10637	2
WP2858	Ectoderm differentiation	4/185	120/6033	0.505221625813848	0.892071544291889	0.888459918606497	1496/8325/5452/7704	4
WP2361	Gastric cancer network 1	1/185	23/6033	0.512106222927309	0.892071544291889	0.888459918606497	6286	1
WP34	Ovarian infertility	1/185	23/6033	0.512106222927309	0.892071544291889	0.888459918606497	1958	1
WP3893	Development and heterogeneity of the ILC family	1/185	23/6033	0.512106222927309	0.892071544291889	0.888459918606497	7704	1
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	1/185	23/6033	0.512106222927309	0.892071544291889	0.888459918606497	6513	1
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	1/185	24/6033	0.52712458378562	0.892071544291889	0.888459918606497	2358	1
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	1/185	24/6033	0.52712458378562	0.892071544291889	0.888459918606497	27035	1
WP3931	Embryonic stem cell pluripotency pathways	3/185	91/6033	0.532622958580932	0.892071544291889	0.888459918606497	2246/2256/8325	3
WP3680	Physico-chemical features and toxicity-associated pathways	2/185	58/6033	0.535497347808554	0.892071544291889	0.888459918606497	8325/4741	2
WP702	Metapathway biotransformation Phase I and II	4/185	125/6033	0.537633528591713	0.892071544291889	0.888459918606497	1543/1591/339761/64090	4
WP231	TNF-alpha signaling pathway	3/185	92/6033	0.540067867812544	0.892071544291889	0.888459918606497	27035/124056/5836	3
WP3613	Photodynamic therapy-induced unfolded protein response	1/185	25/6033	0.541683071387494	0.892071544291889	0.888459918606497	121506	1
WP4969	RAS and bradykinin pathways in COVID-19	1/185	25/6033	0.541683071387494	0.892071544291889	0.888459918606497	1591	1
WP5092	Interactions of natural killer cells in pancreatic cancer	1/185	25/6033	0.541683071387494	0.892071544291889	0.888459918606497	2214	1
WP183	Proteasome degradation	2/185	59/6033	0.544787685540494	0.892071544291889	0.888459918606497	3135/7345	2
WP5090	Complement system in neuronal development and plasticity	3/185	93/6033	0.547445079595758	0.892071544291889	0.888459918606497	1191/78989/286204	3
WP2118	Arrhythmogenic right ventricular cardiomyopathy	2/185	60/6033	0.553948706292877	0.892071544291889	0.888459918606497	782/1496	2
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	1/185	26/6033	0.555795693190642	0.892071544291889	0.888459918606497	8600	1
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	1/185	26/6033	0.555795693190642	0.892071544291889	0.888459918606497	5322	1
WP4155	Endometrial cancer	2/185	61/6033	0.562979567227471	0.892071544291889	0.888459918606497	1496/2246	2
WP4313	Ferroptosis	2/185	61/6033	0.562979567227471	0.892071544291889	0.888459918606497	27035/7018	2
WP2197	Endothelin pathways	1/185	27/6033	0.569476032255022	0.892071544291889	0.888459918606497	4886	1
WP2525	Trans-sulfuration and one-carbon metabolism	1/185	27/6033	0.569476032255022	0.892071544291889	0.888459918606497	23382	1
WP3869	Cannabinoid receptor signaling	1/185	27/6033	0.569476032255022	0.892071544291889	0.888459918606497	1543	1
WP3996	Ethanol effects on histone modifications	1/185	27/6033	0.569476032255022	0.892071544291889	0.888459918606497	9734	1
WP5102	Familial partial lipodystrophy (FPLD)	1/185	27/6033	0.569476032255022	0.892071544291889	0.888459918606497	10365	1
WP5121	Sphingolipid metabolism in senescence	1/185	27/6033	0.569476032255022	0.892071544291889	0.888459918606497	9294	1
WP289	Myometrial relaxation and contraction pathways	4/185	131/6033	0.575084587207138	0.892071544291889	0.888459918606497	816/5569/5333/8787	4
WP5055	Burn wound healing	3/185	97/6033	0.576254769948339	0.892071544291889	0.888459918606497	4314/6280/8796	3
WP4150	Wnt signaling in kidney disease	1/185	28/6033	0.582737260032714	0.892071544291889	0.888459918606497	8325	1
WP4561	Cell migration and invasion through p75NTR	1/185	28/6033	0.582737260032714	0.892071544291889	0.888459918606497	1946	1
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	1/185	28/6033	0.582737260032714	0.892071544291889	0.888459918606497	8600	1
WP4838	Regucalcin in proximal tubule epithelial kidney cells	1/185	28/6033	0.582737260032714	0.892071544291889	0.888459918606497	8600	1
WP5038	Mitochondrial immune response to SARS-CoV-2	1/185	28/6033	0.582737260032714	0.892071544291889	0.888459918606497	27035	1
WP428	Wnt signaling	3/185	98/6033	0.583277548190851	0.892071544291889	0.888459918606497	816/22943/8325	3
WP2374	Oncostatin M signaling pathway	2/185	64/6033	0.589285286969834	0.895989325217291	0.892361838070662	1958/4314	2
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	4/185	134/6033	0.593164010379599	0.896643271504045	0.893013136801599	1958/2904/84894/10603	4
WP4549	Fragile X syndrome	3/185	101/6033	0.60390188138595	0.897697262431058	0.894062860558868	816/54869/2904	3
WP2839	Hair follicle development: organogenesis - part 2 of 3	1/185	30/6033	0.608053083564017	0.897697262431058	0.894062860558868	2246	1
WP4149	White fat cell differentiation	1/185	30/6033	0.608053083564017	0.897697262431058	0.894062860558868	10365	1
WP2636	Common pathways underlying drug addiction	1/185	31/6033	0.620132073992245	0.897697262431058	0.894062860558868	2893	1
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1/185	31/6033	0.620132073992245	0.897697262431058	0.894062860558868	9734	1
WP4241	Type 2 papillary renal cell carcinoma	1/185	31/6033	0.620132073992245	0.897697262431058	0.894062860558868	6513	1
WP2064	Neural crest differentiation	2/185	68/6033	0.622514118726201	0.897697262431058	0.894062860558868	655/9734	2
WP382	MAPK signaling pathway	6/185	210/6033	0.629164493102213	0.897697262431058	0.894062860558868	782/1844/2246/2256/7850/25780	6
WP3995	Prion disease pathway	1/185	32/6033	0.631840765480322	0.897697262431058	0.894062860558868	5452	1
WP3998	Prader-Willi and Angelman syndrome	1/185	32/6033	0.631840765480322	0.897697262431058	0.894062860558868	4948	1
WP4542	Leukocyte-intrinsic Hippo pathway functions	1/185	32/6033	0.631840765480322	0.897697262431058	0.894062860558868	7004	1
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1/185	33/6033	0.643190450263881	0.899083425100049	0.895443411233247	4314	1
WP465	Tryptophan metabolism	1/185	33/6033	0.643190450263881	0.899083425100049	0.895443411233247	1543	1
WP4756	Renin-angiotensin-aldosterone system (RAAS)	1/185	33/6033	0.643190450263881	0.899083425100049	0.895443411233247	816	1
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	2/185	72/6033	0.653641614782261	0.899946774033476	0.896303264826863	22943/8325	2
WP619	Type II interferon signaling	1/185	34/6033	0.654192078047412	0.899946774033476	0.896303264826863	2633	1
WP716	Vitamin A and carotenoid metabolism	1/185	34/6033	0.654192078047412	0.899946774033476	0.896303264826863	195814	1
WP2371	Parkinson's disease pathway	1/185	35/6033	0.664856266338998	0.900257747299899	0.896612979092207	7345	1
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	1/185	35/6033	0.664856266338998	0.900257747299899	0.896612979092207	6513	1
WP5198	Inflammatory bowel disease signaling	1/185	35/6033	0.664856266338998	0.900257747299899	0.896612979092207	50615	1
WP2873	Aryl hydrocarbon receptor pathway	1/185	36/6033	0.675193310474924	0.900257747299899	0.896612979092207	1543	1
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1/185	36/6033	0.675193310474924	0.900257747299899	0.896612979092207	84676	1
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	1/185	36/6033	0.675193310474924	0.900257747299899	0.896612979092207	10410	1
WP4331	Neovascularisation processes	1/185	37/6033	0.685213193343382	0.908956276884078	0.905276291957422	94	1
WP4758	Nephrotic syndrome	1/185	38/6033	0.694925594816276	0.913257376007738	0.909559977724306	4868	1
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	2/185	78/6033	0.696472481139634	0.913257376007738	0.909559977724306	22943/8325	2
WP5124	Alzheimer's disease	6/185	226/6033	0.698993145482846	0.913257376007738	0.909559977724306	22943/8325/2904/3800/27035/10381	6
WP2853	Endoderm differentiation	3/185	118/6033	0.707709055376177	0.919787570792575	0.916063734473577	655/22943/1844	3
WP2059	Alzheimer's disease and miRNA effects	6/185	229/6033	0.711066545112721	0.919787570792575	0.916063734473577	22943/8325/2904/3800/27035/10381	6
WP4963	p53 transcriptional gene network	2/185	81/6033	0.716203498744313	0.920780802472083	0.917052944972196	136/6513	2
WP4290	Metabolic reprogramming in colon cancer	1/185	41/6033	0.722310354542339	0.920780802472083	0.917052944972196	6513	1
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	1/185	42/6033	0.730883883315648	0.920780802472083	0.917052944972196	84676	1
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	1/185	42/6033	0.730883883315648	0.920780802472083	0.917052944972196	7004	1
WP4223	Ras signaling	4/185	161/6033	0.73410302167339	0.920780802472083	0.917052944972196	2904/8399/5322/25780	4
WP2586	Aryl hydrocarbon receptor pathway	1/185	43/6033	0.739194095565123	0.920780802472083	0.917052944972196	1543	1
WP5087	Malignant pleural mesothelioma	10/185	381/6033	0.74103056683982	0.920780802472083	0.917052944972196	1496/22943/1825/1946/2246/2256/8325/4314/6513/7004	10
WP2038	Microtubule cytoskeleton regulation	1/185	44/6033	0.747249035852344	0.920780802472083	0.917052944972196	11076	1
WP2267	Synaptic vesicle pathway	1/185	44/6033	0.747249035852344	0.920780802472083	0.917052944972196	23025	1
WP4861	Endoplasmic reticulum stress response in coronavirus infection	1/185	44/6033	0.747249035852344	0.920780802472083	0.917052944972196	81706	1
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	1/185	45/6033	0.755056504272334	0.9260126939189	0.922263654672264	9415	1
WP4262	Breast cancer pathway	3/185	129/6033	0.763027208430064	0.931394714515572	0.927623885711865	2246/8325/8600	3
WP2272	Pathogenic Escherichia coli infection	1/185	49/6033	0.78395951249636	0.94640305382082	0.942571462509805	10381	1
WP4239	Epithelial to mesenchymal transition in colorectal cancer	3/185	134/6033	0.785235179613633	0.94640305382082	0.942571462509805	8999/9073/8325	3
WP3286	Copper homeostasis	1/185	51/6033	0.797112224407969	0.94640305382082	0.942571462509805	79689	1
WP23	B cell receptor signaling pathway	2/185	96/6033	0.799356854705095	0.94640305382082	0.942571462509805	604/25780	2
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1/185	52/6033	0.803386754412069	0.94640305382082	0.942571462509805	8870	1
WP4906	3q29 copy number variation syndrome	1/185	52/6033	0.803386754412069	0.94640305382082	0.942571462509805	7018	1
WP2431	Spinal cord injury	2/185	98/6033	0.808653244710581	0.94640305382082	0.942571462509805	1958/5322	2
WP4787	Osteoblast differentiation and related diseases	2/185	98/6033	0.808653244710581	0.94640305382082	0.942571462509805	2246/8325	2
WP2795	Cardiac hypertrophic response	1/185	53/6033	0.809468254233799	0.94640305382082	0.942571462509805	9734	1
WP3888	VEGFA-VEGFR2 signaling pathway	10/185	409/6033	0.815233374129092	0.94640305382082	0.942571462509805	1466/22943/1958/10755/9734/3748/5322/5329/9588/7004	10
WP2018	RANKL/RANK signaling pathway	1/185	54/6033	0.815362630984091	0.94640305382082	0.942571462509805	8600	1
WP4541	Hippo-Merlin signaling dysregulation	2/185	101/6033	0.821882620984237	0.948748471942413	0.944907385011472	3681/7004	2
WP710	DNA damage response (only ATM dependent)	2/185	103/6033	0.83024304228394	0.948748471942413	0.944907385011472	604/638	2
WP474	Endochondral ossification	1/185	57/6033	0.831979429241808	0.948748471942413	0.944907385011472	655	1
WP4808	Endochondral ossification with skeletal dysplasias	1/185	57/6033	0.831979429241808	0.948748471942413	0.944907385011472	655	1
WP3651	Pathways affected in adenoid cystic carcinoma	1/185	58/6033	0.837180869266953	0.950511030608768	0.946662807812781	4603	1
WP304	Kit receptor signaling pathway	1/185	59/6033	0.84222213105534	0.952077191627776	0.948222628098919	10603	1
WP4659	Gastrin signaling pathway	2/185	108/6033	0.849624384552235	0.956287186076109	0.952415578035315	1958/3067	2
WP2359	Parkin-ubiquitin proteasomal system pathway	1/185	62/6033	0.856433170970539	0.95979579505319	0.955909982117752	10381	1
WP481	Insulin signaling	3/185	156/6033	0.863454171058754	0.961324846973711	0.957432843544668	1958/10603/6513	3
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	1/185	64/6033	0.86519236227634	0.961324846973711	0.957432843544668	1958	1
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	1/185	66/6033	0.873419857073177	0.966336863144791	0.962424568152302	820	1
WP4949	16p11.2 proximal deletion syndrome	1/185	67/6033	0.87734432941128	0.966565786639546	0.962652564831289	23025	1
WP4656	Joubert syndrome	1/185	71/6033	0.891868424743773	0.970870594335949	0.966939944156451	5145	1
WP4217	Ebola virus infection in host	2/185	124/6033	0.898901158058256	0.970870594335949	0.966939944156451	26762/3135	2
WP51	Regulation of actin cytoskeleton	2/185	127/6033	0.90628539697044	0.970870594335949	0.966939944156451	2246/2256	2
WP2328	Allograft rejection	1/185	76/6033	0.907640585742929	0.970870594335949	0.966939944156451	3135	1
WP4016	DNA IR-damage and cellular response via ATR	1/185	76/6033	0.907640585742929	0.970870594335949	0.966939944156451	604	1
WP3925	Amino acid metabolism	1/185	77/6033	0.910508890533521	0.970870594335949	0.966939944156451	3067	1
WP2355	Corticotropin-releasing hormone signaling pathway	1/185	78/6033	0.913288584162013	0.970870594335949	0.966939944156451	2354	1
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	5/185	265/6033	0.915600694287927	0.970870594335949	0.966939944156451	1946/2246/2256/3681/6513	5
WP4022	Pyrimidine metabolism	1/185	79/6033	0.915982389691825	0.970870594335949	0.966939944156451	956	1
WP1544	MicroRNAs in cardiomyocyte hypertrophy	1/185	80/6033	0.918592946948629	0.970870594335949	0.966939944156451	9734	1
WP254	Apoptosis	1/185	84/6033	0.928252716039909	0.97213094801022	0.968195195184267	8739	1
WP4540	Hippo signaling regulation pathways	1/185	84/6033	0.928252716039909	0.97213094801022	0.968195195184267	7004	1
WP69	T-cell receptor signaling pathway	1/185	86/6033	0.932646041007526	0.97213094801022	0.968195195184267	3604	1
WP399	Wnt signaling pathway and pluripotency	1/185	87/6033	0.934741296163673	0.97213094801022	0.968195195184267	8325	1
WP4657	22q11.2 copy number variation syndrome	1/185	90/6033	0.940645955739724	0.974374296782184	0.97042946157254	150209	1
WP4658	Small cell lung cancer	1/185	93/6033	0.946018983125798	0.976051331796459	0.972099706971372	22798	1
WP5224	2q37 copy number variation syndrome	1/185	104/6033	0.961896984060137	0.988510734607255	0.984508666855809	64090	1
WP4172	PI3K-Akt signaling pathway	4/185	280/6033	0.975741857012967	0.9967862660795	0.992750694152052	1946/2246/2256/22798	4
WP3915	Angiopoietin-like protein 8 regulatory pathway	1/185	125/6033	0.980440607540153	0.9967862660795	0.992750694152052	6513	1
WP366	TGF-beta signaling pathway	1/185	130/6033	0.983318009002062	0.9967862660795	0.992750694152052	2354	1
WP4396	Nonalcoholic fatty liver disease	1/185	137/6033	0.986652576738749	0.9967862660795	0.992750694152052	125965	1
WP3929	Chemokine signaling pathway	1/185	152/6033	0.991730737947302	0.9967862660795	0.992750694152052	6369	1
WP437	EGF/EGFR signaling pathway	1/185	157/6033	0.992952472748425	0.9967862660795	0.992750694152052	2354	1
WP4352	Ciliary landscape	1/185	201/6033	0.998284259703248	0.998284259703248	0.994242623024288	4741	1
